Accredited Investors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
12,096
+146
+1% +$26.5K 0.08% 84
2026
Q1
$1.76M Sell
11,950
-120
-1% -$19.5K 0.09% 75
2025
Q4
$2.35M Buy
12,070
+38
+0.3% +$9.05K 0.12% 65
2025
Q3
$3.38M Buy
12,032
+1,837
+18% +$468K 0.19% 51
2025
Q2
$2.23M Sell
10,195
-511
-5% -$82.5K 0.13% 65
2025
Q1
$1.5M Sell
10,706
-124
-1% -$20.2K 0.09% 72
2024
Q4
$1.8M Buy
10,830
+255
+2% +$45.3K 0.11% 68
2024
Q3
$1.8M Buy
10,575
+398
+4% +$57.6K 0.1% 70
2024
Q2
$1.44M Buy
10,177
+47
+0.5% +$5.84K 0.09% 73
2024
Q1
$1.27M Sell
10,130
-3,206
-24% -$367K 0.08% 81
2023
Q4
$1.41M Hold
13,336
0.1% 74
2023
Q3
$1.41M Buy
13,336
+449
+3% +$52K 0.11% 66
2023
Q2
$1.53M Sell
12,887
-2,352
-15% -$243K 0.11% 61
2023
Q1
$1.42M Sell
15,239
-1,107
-7% -$97.1K 0.11% 61
2022
Q4
$1.34M Buy
16,346
+360
+2% +$27.4K 0.11% 60
2022
Q3
$976K Buy
15,986
+40
+0.3% +$2.93K 0.11% 70
2022
Q2
$1.11M Buy
15,946
+578
+4% +$42.3K 0.13% 65
2022
Q1
$1.27M Buy
15,368
+31
+0.2% +$2.51K 0.11% 66
2021
Q4
$1.34M Sell
15,337
-400
-3% -$37.6K 0.12% 62
2021
Q3
$1.37M Sell
15,737
-400
-2% -$35.3K 0.15% 50
2021
Q2
$1.26M Hold
16,137
0.13% 60
2021
Q1
$1.13M Sell
16,137
-433
-3% -$28K 0.15% 61
2020
Q4
$1.07M Buy
16,570
+333
+2% +$19.8K 0.18% 59
2020
Q3
$969K Sell
16,237
-638
-4% -$36.2K 0.2% 58
2020
Q2
$933K Buy
16,875
+117
+0.7% +$6.2K 0.19% 56
2020
Q1
$810K Sell
16,758
-1,500
-8% -$77.4K 0.19% 54
2019
Q4
$967K Sell
18,258
-267
-1% -$14.7K 0.16% 58
2019
Q3
$1.02M Sell
18,525
-400
-2% -$22.1K 0.2% 50
2019
Q2
$1.08M Sell
18,925
-100
-0.5% -$5.41K 0.21% 52
2019
Q1
$1.02M Sell
19,025
-300
-2% -$15.3K 0.21% 52
2018
Q4
$873K Buy
19,325
+2,785
+17% +$133K 0.2% 52
2018
Q3
$853K Sell
16,540
-305
-2% -$14.8K 0.21% 42
2018
Q2
$742K Buy
16,845
+181
+1% +$8.34K 0.19% 46
2018
Q1
$762K Sell
16,664
-269
-2% -$13.4K 0.21% 41
2017
Q4
$801K Sell
16,933
-3,602
-18% -$177K 0.22% 41
2017
Q3
$993K Buy
20,535
+3,374
+20% +$168K 0.27% 38
2017
Q2
$860K Hold
17,161
0.22% 33
2017
Q1
$766K Buy
17,161
+68
+0.4% +$2.83K 0.19% 39
2016
Q4
$657K Hold
17,093
0.17% 42
2016
Q3
$671K Sell
17,093
-2,727
-14% -$111K 0.18% 40
2016
Q2
$784K Buy
19,820
+1,985
+11% +$79.3K 0.22% 31
2016
Q1
$730K Buy
17,835
+850
+5% +$31.5K 0.19% 35
2015
Q4
$621K Sell
16,985
-2,078
-11% -$79.4K 0.15% 42
2015
Q3
$689K Sell
19,063
-606
-3% -$23.3K 0.19% 36
2015
Q2
$793K Sell
19,669
-7,579
-28% -$329K 0.21% 29
2015
Q1
$1.18M Sell
27,248
-570
-2% -$24.7K 0.3% 23
2014
Q4
$1.25M Buy
27,818
+1,375
+5% +$56K 0.37% 23
2014
Q3
$1.01M Hold
26,443
0.31% 25
2014
Q2
$1.07M Hold
26,443
0.35% 23
2014
Q1
$1.08M Hold
26,443
0.36% 23
2013
Q4
$1.01M Sell
26,443
-652
-2% -$22.4K 0.35% 22
2013
Q3
$899K Hold
27,095
0.33% 22
2013
Q2
$833K Buy
+27,095
New +$899K 0.33% 23

Other funds holding ORCL

Accredited Investors's ORCL Position: Q2 2026 in Review

Accredited Investors increased its Oracle (ORCL) stake by 1.2% in Q2 2026, buying an estimated $26.5K and bringing the position to 12,096 shares worth $1.77M. The position accounts for 0.08% of the portfolio, ranked #84.

Accredited Investors first reported a position in ORCL in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.38M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Accredited Investors held 12,096 shares of Oracle worth $1.77M as of Q2 2026.
  • Accredited Investors bought 146 Oracle shares in Q2 2026, an estimated $26.5K.
  • Oracle made up 0.08% of Accredited Investors's portfolio in Q2 2026, its #84 holding.
  • Accredited Investors first reported a position in Oracle in Q2 2013 and has held it in 53 quarters since.
  • Accredited Investors's Oracle position peaked at $3.38M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.